Author(s):
1. Sahrai Saeed:
Department of Heart Disease, Haukeland University Hospital,
Bergen, Norway.
2. Ronak Rajani:
Cardiothoracic Centre, Guy’s & St Thomas’ NHS Foundation Trust,
London, United Kingdom.
School of Biomedical Engineering and Imaging Sciences,
King’s College London, United Kingdom.
Abstract:
At the end of 2019 a novel coronavirus was identified in Wuhan, China. The disease caused by the severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) was designated COVID-19 (corona virus disease 2019) by the World Health Organization in early 2020. Up to 80% of patients with COVID-19 experience mild symptoms with severe or critical disease occurring in the remaining 20%. Severe disease is manifested by the development of pneumonia, hypoxia and radiographic lung involvement while critical disease indicates multiorgan involvement with significant respiratory or cardiac compromise. The current estimated case fatality rate from COVID-19 is approximately 1%. Epidemiological studies have shown that advanced age, male gender, previous chronic lung disease, cardiovascular and kidney disease, obesity and diabetes are risk factors for the severity of disease course. In the current focused review, we present an overview of the acute cardiovascular complications of COVID-19, their detection and impact upon prognosis.
Page(s):
908-912
DOI:
DOI not available
Published:
Journal: Pakistan Journal of Medical Sciences, Volume: 37, Issue: 3, Year: 2021
Keywords:
COVID19
,
Coronavirus disease 2019
,
Hypertension
,
prognosis
,
Acute cardiac injury
,
Cardiovascular complications
,
Antihypertensive treatment
References:
References are not available for this document.
Citations
Citations are not available for this document.